Market ChallengesThe headwinds that impacted Q4 have not subsided and are likely to create some challenges throughout 2024, including softening demand and inventory rebalancing in the Industrials and Medical markets and continued weakness in Computing and Telecom.
Revenue GuidanceEPS at the midpoint of the Q2 guide (including SBC) was slightly below Street expectations.
Revenue PerformanceThe 3% y/y decline in revenue was primarily driven by softness in the Medical, Industrials, and Communications segments.